Law-Firm Blogs: Marketing Device or Mere Diversion?
That was the question posed Friday by Dechert’s James Beck and Jones Day’s Mark Herrmann, co-authors of the well-read Drug and Device Law blog. Given that, for instance, Drug and Device scores 25,000 page views per month, “wouldn’t you expect at least a few of your colleagues to wander down the hall and ask two questions: (1) How did you do it? and (2) How can we replicate it?” ask Beck and Hermann. They propose four possible answers.
Read more at blogs.wsj.com.comments powered by Disqus